Jio Health, a leading provider of human-centered, technology-powered healthcare, has completed a $20M Series B investment led by Singapore-based healthcare investor, Heritas Capital. Other investors in the round include Fuchsia Ventures, Kasikorn Bank Group, and existing investor, Monk’s Hills Ventures.

This fundraise represents the largest in the company’s history and will build on Jio Health’s aggressive growth, with plans to expand its Smart Clinics and omni-channel ecosystem across its primary market of Vietnam and pave the way for expansion into regional markets over the coming years.

“We’re excited to welcome a high-impact, high-conviction cohort of investors to join us on our mission to become the most consumer-centric healthcare company in Vietnam and across Southeast Asia. We plan to boldly invest into expanding our geographic footprint across Vietnam, enhancing our clinical and digital capabilities, and regionalizing the playbook for our “quality care, anytime, anywhere” value proposition.” said Jio Health’s Founder & CEO, Raghu Rai.

The Series B investment in Jio Health will extend its clinical service offering to more consumers and employers, support the launch of additional Smart Clinics in existing and new geographies, expand provider and clinical support teams, and further advance technology platform innovation.

Chik Wai Chiew, the CEO and Executive Director of Heritas Capital said, “Jio Health is building a unique healthcare model with a blend of online and in-person service offerings to care for patients throughout their healthcare journey, from wellness to treatment and post-treatment recovery. We are pleased to support Jio Health in their mission to provide greater access to affordable quality healthcare solutions and managed care for all.”

Jio Health’s vertically integrated consumer healthcare value chain enables it to provide quality, affordable care wherever consumers shop, work, live, and click. The uniqueness of Jio Health’s model is that access to care is part of a larger omni-channel strategy that integrates prevention, multi-specialty care management, and ancillary diagnostic and pharmacy benefits to deliver better healthcare outcomes.